The UALCAN and GEPIA databases suggested that EIF4A3 was highly expressed in CCA (also called CHOL) samples (Fig. 4D), which suggested a lower survival of CCA cases (Fig. 4E). The gene discussed is EIF4A3; the disease is cholangiocarcinoma.